381 related articles for article (PubMed ID: 32286715)
1. Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
Ezeh U; Ida Chen YD; Azziz R
Clin Endocrinol (Oxf); 2020 Aug; 93(2):163-172. PubMed ID: 32286715
[TBL] [Abstract][Full Text] [Related]
2. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
4. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
Ezeh U; Pisarska MD; Azziz R
Hum Reprod; 2022 Mar; 37(3):553-564. PubMed ID: 35048126
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.
Kauffman RP; Baker VM; Dimarino P; Gimpel T; Castracane VD
Am J Obstet Gynecol; 2002 Nov; 187(5):1362-9. PubMed ID: 12439532
[TBL] [Abstract][Full Text] [Related]
6. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.
Ezeh U; Chen IY; Chen YH; Azziz R
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2408-20. PubMed ID: 32382742
[TBL] [Abstract][Full Text] [Related]
8. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake.
Ezeh U; Chen IY; Chen YH; Azziz R
Clin Endocrinol (Oxf); 2019 Apr; 90(4):542-552. PubMed ID: 30623452
[TBL] [Abstract][Full Text] [Related]
10. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study.
He S; Ji D; Liu Y; Deng X; Zou W; Liang D; Du Y; Zong K; Jiang T; Li M; Zhang D; Yue X; Tao F; Cao Y; Liang C
J Assist Reprod Genet; 2023 Aug; 40(8):1983-1993. PubMed ID: 37358742
[TBL] [Abstract][Full Text] [Related]
12. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
[TBL] [Abstract][Full Text] [Related]
13. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome.
Andrisse S; Garcia-Reyes Y; Pyle L; Kelsey MM; Nadeau KJ; Cree-Green M
J Endocr Soc; 2021 Apr; 5(4):bvab008. PubMed ID: 33644620
[TBL] [Abstract][Full Text] [Related]
15. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
16. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
17. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
18. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome.
Mu L; Zhao Y; Lai Y; Li R; Qiao J
Clin Endocrinol (Oxf); 2018 Dec; 89(6):779-788. PubMed ID: 30106166
[TBL] [Abstract][Full Text] [Related]
20. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
Sam S; Scoccia B; Yalamanchi S; Mazzone T
Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]